Tenex Genomics Stock Surges on Analyst Buy Rating
Update: 2025-12-22
Description
Ten ex Genomics shares surge 4.8% as analysts maintain bullish stance; stock still below 52-week high, long-term investors face losses, but potential turnaround seen with renewed funding in biotech research.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
